Drug therapy of hyperlipoproteinemias
Dalmau Serra, J.
Anales Espanoles de Pediatria 35(Suppl 45): 20-21
1991
ISSN/ISBN: 0302-4342 PMID: 1763865 Document Number: 376028
Document emailed within 1 workday
Related Documents
Haacke, H.; Kolenda, K.D. 1976: Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs Medizinische Klinik 71(12): 513-517Tan, M.H. 1981: Dietary therapy of hyperlipoproteinemias: new understandings Annals of the Academy of Medicine Singapore 10(4 Suppl): 77-81
Grzeskowiak, B.; Singer, P.; Gnauck, G.; Honigmann, G.; Stolz, P.; Schliack, V. 1973: Diet therapy of hyperlipoproteinemias from the diabetological viewpoint Das Deutsche Gesundheitswesen 28(5): 197-202
Richter, W.O. 1996: Lipid metabolism disorders--diagnosis and therapy in general practice. 8: Mixed hyperlipoproteinemias Fortschritte der Medizin 114(18-19): 248-250
Ceska, R.; Cífková, R.; Poledne, R.; Rosolová, H.; Soska, V.; Simon, J.; Sobra, J.; Vaverková, H.; Widimský, J.; Widimský, J.; Zadák, Z. 1997: Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society Casopis Lekaru Ceskych 136(8): 257-261
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Iimori, M. 2005: Psychotherapy and drug therapy--drug therapy within the framework of psychotherapy and psychotherapy conducted during drug therapy Seishin Shinkeigaku Zasshi 107(5): 500-505
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Bunton, R.W. 1983: Reintroduction of anti-inflammatory drug therapy after drug-associated gastrointestinal disturbances New Zealand Medical Journal 96(726): 144
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Ishihara, H. 2011: Treatment for exacerbation--drug and non-drug therapy, criteria of hospitalization and ICU admission Nihon Rinsho. Japanese Journal of Clinical Medicine 69(10): 1863-1868
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Zabel, R. 1974: Classification of hyperlipoproteinemias Dermatologische Monatschrift 160(2): 134-150
Polano, M.K. 1977: Xanthomas and hyperlipoproteinemias Nederlands Tijdschrift Voor Geneeskunde 121(31): 1235-1241
Ogawa, Y.; Toguchi, H. 1990: Targeting therapy with a drug using temperature-sensitive liposomes entrapped antitumor drug together with localized hyperthermia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(6): 1127-1133
Robinson, L.A. 1979: Pediatric drug information: drug therapy in nursing mothers Pediatric Nursing 5(6): 68-69; 84
Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Pearce, M.J.; Begg, E.J. 1994: Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system New Zealand Medical Journal 107(974): 101-104